Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Frontiers in Oncology
|
January 3, 2022
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, et al.
Expert Opinion on Investigational Drugs
|
December 14, 2020
Nivolumab: an investigational agent for the treatment of biliary tract cancer
Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, et al.
Translational Cancer Research
|
February 4, 2022
Adjuvant treatment in biliary tract cancer
Andrea Palloni, Giorgio Frega, Stefania De Lorenzo, et al.
Frontiers in Pharmacology
|
November 16, 2020
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, et al.
Cells
|
August 26, 2023
Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
Giorgio Frega, Fernando P Cossio, Jesus M Banales, et al.
Plos One
|
August 23, 2012
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations
Giovanni Brandi, Simona Tavolari, Francesco De Rosa, et al.
Future Oncology (London, England)
|
June 5, 2019
BAP1 in solid tumors
Vincenzo Di Nunno, Giorgio Frega, Matteo Santoni, et al.
Langenbeck'S Archives of Surgery
|
February 24, 2023
Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?
Andrea Laurenzi, Giovanni Brandi, Federica Greco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 18, 2023
Myoepithelial carcinoma of soft tissues and bone
Hisaki Aiba, Costantino Errani, Giovanni Ciani, et al.
In Vivo (Athens, Greece)
|
March 1, 2020
Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis
Alessandro Rizzo, Giorgio Frega, Angela Dalia Ricci, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Frontiers in Oncology
|
January 3, 2022
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, et al.
Expert Opinion on Investigational Drugs
|
December 14, 2020
Nivolumab: an investigational agent for the treatment of biliary tract cancer
Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, et al.
Translational Cancer Research
|
February 4, 2022
Adjuvant treatment in biliary tract cancer
Andrea Palloni, Giorgio Frega, Stefania De Lorenzo, et al.
Frontiers in Pharmacology
|
November 16, 2020
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, et al.
Cells
|
August 26, 2023
Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
Giorgio Frega, Fernando P Cossio, Jesus M Banales, et al.
Plos One
|
August 23, 2012
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations
Giovanni Brandi, Simona Tavolari, Francesco De Rosa, et al.
Future Oncology (London, England)
|
June 5, 2019
BAP1 in solid tumors
Vincenzo Di Nunno, Giorgio Frega, Matteo Santoni, et al.
Langenbeck'S Archives of Surgery
|
February 24, 2023
Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?
Andrea Laurenzi, Giovanni Brandi, Federica Greco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 18, 2023
Myoepithelial carcinoma of soft tissues and bone
Hisaki Aiba, Costantino Errani, Giovanni Ciani, et al.
In Vivo (Athens, Greece)
|
March 1, 2020
Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis
Alessandro Rizzo, Giorgio Frega, Angela Dalia Ricci, et al.
Page
of 6